Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ADC, antibody, antigen, arrangement, begun, blockade, breach, Bulgaria, ceiling, center, Chew, civil, Columbia, Consumer, contend, counting, CRT, cytochrome, deadline, diversion, docetaxel, dog, endocrine, enzyme, Estonia, experimental, forum, Fraud, fulfilled, gave, gBRCAm, HRSA, IB, IIIA, induction, intervene, LEAP, lost, lymph, median, MMWR, modest, nationwide, neurological, node, Orion, overcharging, plaintiff, point, prohibit, prohibited, Quebec, rebate, Romanian, routine, security, Sichuan, Slovenia, steroid, strike, trophoblast, uHCC, unanimously, undergone, unlawful, unnamed, warranty
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view